What our partners say about us!

The best promotion we can put forward is what our partners say about their experience with CER Groupe!

The success of the CER Groupe is exceptional! It is the result of a very pragmatic and effective vision over the years! It is with great pleasure and conviction that I am working with them for Univercells, which brings together various companies active in bioproduction. The CER Groupe is a trusted partner for R&D developments. We collaborate closely in non-clinical in-vivo and in-vitro developments as part of our proof of concept for vaccine or therapeutic leads. The CER Groupe provides high-quality services! Their rigor, operational excellence and flexibility deserve to be highlighted!

Hugues BULTOT CEO & co-founder - Univercells Group

I am delighted to collaborate with a Walloon company with extensive experience in pre-clinical studies and CRO services. Its expertise in cell therapy, which it has acquired over the last 12 years, is remarkable. They have animal models of various types that allow us to reliably test and analyze the impact of our therapeutic vaccines derived from a PDC cell line. They are able to conduct pre-clinical animal studies with ‘complex’ protocols in a GLP environment. During the six years of our collaboration, we have noticed the great flexibility and the high-quality follow-up of CER teams.

Eric HALIOUA CEO - PDC*line Pharma

Having a Research Centre like CER Groupe is a wonderful asset for Wallonia. Their expertise, the quality of their work and the extensive range of services that they offer make CER Groupe an essential player! The Walloon and Belgian biotech ecosystem is a high-performing ecosystem in which I have great faith. I therefore encourage my team and my network to develop collaborations with CER Groupe, in order to take advantage of their skills and consolidate their local roots. CER Groupe’s reputation is one of its strengths. I support Olivier Vanloocke, Francois Cote, Marie-Ange Benoit and all the other members of the team in capitalising on the skills of the Centre d’Etudes et de Recherches to guarantee their development in Wallonia, Belgium and most certainly in Europe.

Marc DECHAMPS CEO of @Bioxodes, Joint academic director at @Solvay BSEM for the Advanced Master Biotech & MedTech Ventures programme and Chairman of @Investsud tech

CER Groupe is a partner of choice for Immunochem! Thanks to their scientific expertise, we are able to produce antibodies against small molecules which are exceptional! Thanks to our joint expertise, we are able to offer our clients molecules that are adapted to their needs (high affinity and low cross-reactivity). Innovation is one of our common values. CER Groupe’s teams listen and are prepared to adapt to the needs/requests of their clients, with the aim of finding increasingly innovative solutions. Our fruitful collaboration will continue over the coming years, especially thanks to the Walloon Region’s financial support to our projects, in particular to build our platform to discover single-domain antibodies, as well as to develop a process to develop recombinant antibodies from earlier-generation antibodies.

Philippe HERMAN CEO Immunochem